SWOG clinical trial number
SWOG-8391
Intergroup Adult Adjuvant Soft Tissue Sarcoma Protocol #2, A Randomized Trial of Adjuvant Doxorubicin vs. Standard Therapy (A Delay of Chemotherapy Until the Time of Possible Relapse)
Closed
Phase
Published
Abbreviated Title
Intergroup Adult Adjuvant Soft Tissue Sarcoma Protocol #2, A Randomized Trial of Adjuvant Doxorubicin vs. Standard Therapy (A Delay of Chemotherapy Until the Time of Possible Relapse)
Activated
02/18/1983
Closed
06/15/1986
Publication Information Expand/Collapse
1991
Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of the literature.
1990
Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results.
1987
A preliminary analysis of a randomized intergroup (SWOG, ECOG< CALGB, NCOG) trial of adjuvant doxorubicin for soft tissue sarcomas.
A randomized intergroup trial of adjuvant doxorubicin (DOX) for soft tissue sarcomas (STS): Lack of apparent difference between treatment groups.